Nigeria Centre for Disease Control (NCDC) has announced one new death from coronavirus after three days of no record of fatality.
Also, about 214 people tested positive for COVID-19 in Nigeria on Tuesday, making total infections in the country increase to 162,076 with 2,031 deaths.
The 214 new cases were reported from 12 states: Adamawa (109), Lagos (33), Bauchi (26), Kaduna (9), Rivers (9), FCT (7), Oyo (7), Gombe (5), Ebonyi (4), Osun (3), Ekiti (1), and Ogun (1).
For the first time this month, Adamawa had the highest figure with 109 new cases on Tuesday; followed by Lagos, the most impacted city in Nigeria, with 33 new cases.
214 new cases of #COVID19Nigeria;
Adamawa-109
Lagos-33
Bauchi-26
Kaduna-9
Rivers-9
FCT-7
Oyo-7
Gombe-5
Ebonyi-4
Osun-3
Ekiti-1
Ogun-1162,076 confirmed
148,530 discharged
2,031 deaths pic.twitter.com/tV9fcKjF8J— NCDC (@NCDCgov) March 23, 2021
In the past one week, there has been a marginal decline in new cases as daily infections have fallen below 300.
NCDC’s data also suggests that Africa’s most populous nation may have gone past its worst phase of the virus although experts warns it might be too early to celebrate.
Today’s report includes:
✅157 community recoveries in Bauchi State, 121 in FCT and 55 in Lagos State managed in line with guidelines
✅Backlog of cases from Adamawa State recorded from the 10th of March, 2021A breakdown of cases by state via https://t.co/zQrpNf5Q61 pic.twitter.com/8Ov7dJHLTa
— NCDC (@NCDCgov) March 23, 2021
Since the pandemic broke out in Nigeria in February last year, the country has carried out over 1.7 million tests.
More than two-thirds of the over 161,000 people infected by COVID-19 in Nigeria have recovered after treatment.
According to NCDC data published Sunday night, a total of 148,530 people have recovered after treatment.
Meanwhile, over 11,000 infections are still active in the country.
Authorities on Tuesday announced that over 200,000 Nigerians have received jabs from the nearly 4 million doses of Oxford-AstraZeneca COVID-19 vaccine that were shipped to the country earlier this month by the Vaccines Global Access facility – COVAX.
Nigeria is also expecting 41 million doses through the African Union.
The west African nation aims to vaccinate 109 million people against the COVID-19 virus over a period of two years. Only eligible population from 18 years and above will be vaccinated.
To achieve this, authorities said the vaccine roll-out will be in four phases, starting with health workers, frontline workers, COVID-19 rapid response team, laboratory network, police officers, petrol station workers and strategic leaders.
Read Also: COVID-19 Vaccine: ‘No Nigerian Has So Far Developed Severe Side Effects’ – NPHCDA
Faisal Shuaib, the Executive Director of the National Primary Health Care Development Agency (NPHCDA) while speaking at Monday’s briefing of Presidential Task Force (PTF) on COVID-19 said Nigeria has not recorded any serious adverse reaction following the administration of the Oxford-AstraZeneca COVID-19 vaccines.
